Myomo, Inc. (MYO) Analysts See $-0.19 EPS

July 14, 2018 - By Alicia Butler

Analysts expect Myomo, Inc. (NYSEAMERICAN:MYO) to report $-0.19 EPS on August, 13.They anticipate $0.87 EPS change or 82.08 % from last quarter’s $-1.06 EPS. After having $-0.20 EPS previously, Myomo, Inc.’s analysts see -5.00 % EPS growth. The stock increased 0.88% or $0.02 during the last trading session, reaching $2.28. About 146,248 shares traded. Myomo, Inc. (NYSEAMERICAN:MYO) has 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States. The company has market cap of $28.30 million. The firm develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits. It currently has negative earnings.

Myomo, Inc. (NYSEAMERICAN:MYO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: